Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Anthera Pharmaceuticals Inc. buy Maxi_Scalibusa

Anthera Pharmaceuticals Inc.
Start price
€2.16
23.02.18 / 50%
Target price
€3.61
15.03.18
Performance (%)
-81.38%
End price
€0.40
15.03.18
Summary
This prediction ended on 15.03.18 with a price of €0.40. Massive losses of -81.38% were the result for the BUY prediction by Maxi_Scalibusa. Maxi_Scalibusa has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Anthera Pharmaceuticals Inc. - - - -
iShares Core DAX® -0.874% 5.325% 6.865% 65.211%
iShares Nasdaq 100 -0.381% 1.979% 25.696% 90.325%
iShares Nikkei 225® -1.676% 1.952% 41.443% 80.623%
iShares S&P 500 -0.655% 2.069% 21.405% 70.737%

Comments by Maxi_Scalibusa for this prediction

In the thread Anthera Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -81.38%
Target price 3.608
Change
Ends at 15.03.18

Maxi-Scalibusa stimmt der Buy-Einschätzung von stratec zu

Maxi-Scalibusa stimmt am 22.02.2018 der Buy-Einschätzung von stratec mit dem Kursziel 4$ zu.
Überschrift: Anthera Pharmaceuticals initiated with Buy rating and $10 (492% upside) price target at ROTH Capital.

Maxi_Scalibusa 
0
Report Share
23.02.18
Prediction Buy
Perf. (%) -81.38%
Target price 3.608
Change
Ends at 15.03.18

(Vom Mitglied beendet)

Maxi_Scalibusa 
0
Report Share
15.03.18